Usefulness of presepsin in the diagnosis of sepsis in patients with or without acute kidney injury

BMC Anesthesiology

Volumn 14, Issue 1, 2014, Pages

  Nakamura, Yoshihiko ^a   Ishikura, Hiroyasu ^a   Nishida, Takeshi ^a   Kawano, Yasumasa ^a   Yuge, Rie ^a   Ichiki, Reiko ^a   Murai, Akira ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Acute kidney injury; Diagnosis; Presepsin; RIFLE criteria; Sepsis

Indexed keywords

LYMPHOCYTE ANTIGEN; PRESEPSIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CD14 ANTIGEN; PEPTIDE FRAGMENT; PRESEPSIN PROTEIN, HUMAN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FUNGUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; RETROSPECTIVE STUDY; RIFLE CRITERIA; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPTIC SHOCK; ACUTE KIDNEY INJURY; ADOLESCENT; BLOOD; CHRONIC KIDNEY FAILURE; COMPLICATION; GLOMERULUS FILTRATION RATE; KIDNEY FUNCTION TEST; MIDDLE AGED; REPRODUCIBILITY; YOUNG ADULT;

ACUTE KIDNEY INJURY; ADOLESCENT; ADULT; AGED; ANTIGENS, CD14; BIOLOGICAL MARKERS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SEPSIS; YOUNG ADULT;

EID: 84922244491     PISSN: None     EISSN: 14712253     Source Type: Journal    
DOI: 10.1186/1471-2253-14-88     Document Type: Article

References (23)

1. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American college of chest physicians/society of critical care medicine. Chest 1992, 101:1644-1655. 10.1378/chest.101.6.1644, 1303622.
2. Battleman DS, Callahan M, Thaler HT. Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: link between quality of care and resource utilization. Arch Intern Med 2002, 162:682-688. 10.1001/archinte.162.6.682, 11911722.
3. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34:1589-1596. 10.1097/01.CCM.0000217961.75225.E9, 16625125.
4. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, . Early Goal-Directed Therapy Collaborative G Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377. 10.1056/NEJMoa010307, 11794169, Early Goal-Directed Therapy Collaborative G.
5. Bhatia BD, Basu S. Newer diagnostic tests for bacterial diseases. Indian J Pediatr 2007, 74:673-677. 10.1007/s12098-007-0119-6, 17699977.
6. Herzum I, Renz H. Inflammatory markers in SIRS, sepsis and septic shock. Curr Med Chem 2008, 15:581-587. 10.2174/092986708783769704, 18336272.
7. Christ-Crain M, Muller B. Procalcitonin in bacterial infections-hype, hope, more or less?. Swiss Med Wkly 2005, 135:451-460.
8. Oda S, Hirasawa H, Shiga H, Nakanishi K, Matsuda K, Nakamua M. Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis. Cytokine 2005, 29:169-175. 10.1016/j.cyto.2004.10.010, 15652449.
9. Abe R, Oda S, Sadahiro T, Nakamura M, Hirayama Y, Tateishi Y, Shinozaki K, Hirasawa H. Gram-negative bacteremia induces greater magnitude of inflammatory response than gram-positive bacteremia. Critical care (London, England) 2010, 14:R27.
10. Endo S, Suzuki Y, Takahashi G, Shozushima T, Ishikura H, Murai A, Nishida T, Irie Y, Miura M, Iguchi H, Fukui Y, Tanaka K, Nojima T, Okamura Y. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infec Chemother Official J Japan Soc Chemotherap 2012, 18:891-897.
11. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, . Acute Dialysis Quality Initiative w Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the acute dialysis quality initiative (ADQI) group. Critical care (London, England) 2004, 8:R204-R212. Acute Dialysis Quality Initiative w.
12. Kurihara T, Yanagida A, Yokoi H, Koyata A, Matsuya T, Ogawa J, Okamura Y, Miyamoto D. Evaluation of cardiac assays on a benchtop chemiluminescent enzyme immunoassay analyzer, PATHFAST. Anal Biochem 2008, 375:144-146. 10.1016/j.ab.2007.12.030, 18211813.
13. Okamura Y, Yokoi H. Development of a point-of-care assay system for measurement of presepsin (sCD14-ST). Clinica Chim Acta Int J Clinical Chem 2011, 412:2157-2161.
14. Ricci Z, Ronco C, D'Amico G, De Felice R, Rossi S, Bolgan I, Bonello M, Zamperetti N, Petras D, Salvatori G, Dan M, Piccinni P. Practice patterns in the management of acute renal failure in the critically ill patient: an international survey. Nephrol dialysis Transplant Official Publ European Dialysis Transpl Assoc European Renal Assoc 2006, 21:690-696.
15. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A, . Collaborators developing the Japanese equation for estimated GFR Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis Official J Nat Kidney Found 2009, 53:982-992. Collaborators developing the Japanese equation for estimated GFR.
16. Furusako SSK. Methods for detecting human low molecular weight CD14. United States Patent 2008, B2:US7465547.
17. Furusako SSK, Hirose J. Soluble CD14 antigen. United States Patent 2009, B2:US7608684.
18. Naito K. Method for evaluation of function of phagocyte. United States Patent 2011, A1:US0086381.
19. Shozushima T, Takahashi G, Matsumoto N, Kojika M, Okamura Y, Endo S. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. J Infect Chemotherap Official J Japan Soc Chemotherap 2011, 17:764-769.
20. Murugan R, Kellum JA. Acute kidney injury: what's the prognosis?. Nat Rev Nephrol 2011, 7:209-217. 10.1038/nrneph.2011.13, 3547642, 21343898.
21. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA J Am Med Assoc 1995, 273:117-123.
22. Yaegashi Y, Shirakawa K, Sato N, Suzuki Y, Kojika M, Imai S, Takahashi G, Miyata M, Furusako S, Endo S. Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis. J Infect Chemotherap Official J Japan Soc Chemotherap 2005, 11:234-238.
23. Shirakawa K, Naitou K, Hirose J, Takahashi T, Furusako S. Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients. Clinical Chem Lab Med CCLM / FESCC 2011, 49:937-939.